Mankind Pharma forays into cat food segment, launches PetStar Delight

Mankind Pharma has taken a decisive step in strengthening its presence within India’s rapidly evolving pet care ecosystem with the launch of PetStar Delight, a scientifically crafted cat nutrition portfolio that officially expands the company’s footprint beyond its established dog food line. Announced on Thursday, this launch marks a strategic move into the country’s cat food market, a segment that has become one of the most dynamic categories in India’s booming pet industry. With the overall cat food sector now valued at approximately ₹1,500 crore and growing at nearly twenty percent year on year, it reflects both a shift in consumer behaviour and a broader cultural transition: Indian households, especially in urban centres, are increasingly embracing cats as companion animals, and with that comes the demand for reliable, premium, and targeted nutrition. As lifestyles change and nuclear family structures solidify in city environments, pets are becoming integral to everyday emotional and social well-being, and choosing the right food is now considered an essential part of responsible ownership. Recognising this momentum early on, Mankind Pharma ventured into the pet care space in 2022 with the debut of PetStar, its dog food range, which steadily gained traction over the past three years. Company leadership observed a sustained rise in organised pet care spending during this period, driven not only by the expanding penetration of retail channels but also by increasing awareness among consumers regarding ingredient quality, functional nutrients, and the long-term health implications of scientifically backed diets. This evolving mindset is precisely what led Mankind Pharma to deepen its commitment by entering the cat segment, which Vice Chairman and Managing Director Rajeev Juneja describes as one of the fastest-expanding pockets of India’s overall pet care landscape. According to Juneja, the launch of PetStar Delight reflects the company’s larger ambition to build a scientifically informed, species-specific nutrition portfolio rooted in research, veterinary insights, and global best practices. What sets PetStar Delight apart is its focus on targeted formulations designed around the unique physiological and behavioural needs of cats—animals with digestive, urinary, and metabolic systems significantly different from dogs. Dr. Piyush Prashant, who heads Mankind Pharma’s pet food division, noted that the new range incorporates functional ingredients aimed at addressing some of the most common feline health concerns. Among these are gut comfort, which helps ensure stable digestion in a species prone to sensitivity; urinary health support, which is crucial because cats often experience urinary tract issues due to their naturally low water intake; and hairball management, a key area of concern for cat parents as shedding and self-grooming lead to ingestion of loose fur. The formulations also include nutrients associated with cognitive development and brain function, especially important for kittens and young adults whose neurological growth stages rely heavily on specific amino acids and fatty acids. Dr. Prashant emphasised that modern pet owners are becoming increasingly conscious readers of labels—they want to know not only what is in their cat’s food but why each ingredient is included and how it contributes to long-term vitality. This shift has elevated the importance of functional nutrition and evidence-based formulation, pushing brands to move beyond generic recipes and adopt more precise, purpose-driven blends. PetStar Delight is produced in Thailand, a country widely recognised as a global manufacturing hub for high-quality pet food owing to its advanced processing facilities, stringent quality standards, and strong presence in international supply chains. Manufacturing in Thailand allows Mankind Pharma to ensure consistency, safety, and premium-grade ingredient sourcing—three qualities increasingly sought by Indian consumers who are moving toward global-standard products in the pet category. The decision also aligns with the company’s strategy of positioning PetStar Delight as a reliable, science-focused option that competes not only with domestic brands but also with established multinational players already active in India’s cat food space. Distribution will take place through Mankind Pharma’s extensive retail and trade network, which has been central to the success of its dog food line and provides strong last-mile reach into both urban and emerging markets. By leveraging this infrastructure, the company aims to make specialised cat nutrition accessible to a wider audience, bridging the gap between awareness and availability. The product line will debut with three flavour variants, each designed to appeal to feline palates while maintaining nutritional integrity. Although the specific flavours have not yet been publicly detailed, Mankind Pharma has hinted that they are based on extensive palatability studies and global trends in feline taste preferences. This diversified flavour offering is likely to cater to both selective eaters—a common trait among cats—and households with multiple pets requiring variety. With the introduction of PetStar Delight, Mankind Pharma signals a deeper commitment to shaping India’s premium pet nutrition space, a sector that has witnessed increased investment from both local and international players over the past five years. As disposable incomes rise, pet adoption grows, and the conversation around pet wellness becomes more mainstream, brands are competing not only through marketing but through formulation research, product innovation, and credibility. The entry of large pharmaceutical companies like Mankind into this arena reflects a broader trend of institutional interest in the pet industry—a market once considered niche but now recognised as a fast-scaling consumer goods opportunity. Overall, the launch of PetStar Delight is more than just a product addition—it represents an evolution in how Indian companies view the pet care sector and the sophistication with which they approach nutrition science. By focusing on functional benefits, international manufacturing standards, and a research-driven development pipeline, Mankind Pharma is positioning itself to play a long-term role in shaping the future of India’s cat food market. As pet parents continue to seek trusted, transparent, and high-quality options, the company’s strategic timing and scientific approach may well place PetStar Delight at the forefront of the country’s growing feline nutrition movement.